CO5670360A2 - Dispositivo de retencion gastrico expandible - Google Patents

Dispositivo de retencion gastrico expandible

Info

Publication number
CO5670360A2
CO5670360A2 CO04023075A CO04023075A CO5670360A2 CO 5670360 A2 CO5670360 A2 CO 5670360A2 CO 04023075 A CO04023075 A CO 04023075A CO 04023075 A CO04023075 A CO 04023075A CO 5670360 A2 CO5670360 A2 CO 5670360A2
Authority
CO
Colombia
Prior art keywords
retention device
gastric retention
expandable gastric
expandable
polysaccharide
Prior art date
Application number
CO04023075A
Other languages
English (en)
Spanish (es)
Inventor
James W Ayres
Original Assignee
Oregon State Board Of Higher Education
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oregon State Board Of Higher Education filed Critical Oregon State Board Of Higher Education
Publication of CO5670360A2 publication Critical patent/CO5670360A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0409—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is not a halogenated organic compound
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0409—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is not a halogenated organic compound
    • A61K49/0414—Particles, beads, capsules or spheres
    • A61K49/0419—Microparticles, microbeads, microcapsules, microspheres, i.e. having a size or diameter higher or equal to 1 micrometer

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
CO04023075A 2001-08-16 2004-03-12 Dispositivo de retencion gastrico expandible CO5670360A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US31307801P 2001-08-16 2001-08-16

Publications (1)

Publication Number Publication Date
CO5670360A2 true CO5670360A2 (es) 2006-08-31

Family

ID=23214285

Family Applications (1)

Application Number Title Priority Date Filing Date
CO04023075A CO5670360A2 (es) 2001-08-16 2004-03-12 Dispositivo de retencion gastrico expandible

Country Status (14)

Country Link
EP (1) EP1416914A1 (fr)
JP (1) JP2005501097A (fr)
KR (1) KR20040032918A (fr)
CN (1) CN1543337A (fr)
BR (1) BR0117123A (fr)
CA (1) CA2456976A1 (fr)
CO (1) CO5670360A2 (fr)
IL (1) IL160363A0 (fr)
MX (1) MXPA04001388A (fr)
NO (1) NO20040611L (fr)
NZ (1) NZ531461A (fr)
PL (1) PL368327A1 (fr)
WO (1) WO2003015745A1 (fr)
ZA (1) ZA200402066B (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2004119035A (ru) 2001-11-21 2005-11-20 Э-З-Эм, Инк. (Us) Композиции, предназначенные для применения в медицинских и диагностических процедурах
AU2004308419B2 (en) * 2003-12-24 2011-06-02 Victory Pharma, Inc. Enhanced absorption of modified release dosage forms
US7699863B2 (en) 2005-03-01 2010-04-20 Tulip Medical Ltd. Bioerodible self-deployable intragastric implants
US7785291B2 (en) 2005-03-01 2010-08-31 Tulip Medical Ltd. Bioerodible self-deployable intragastric implants
US20080075658A1 (en) * 2006-07-19 2008-03-27 Burke Matthew D Method of Radiolabeling Formulations for Gamma Scintigraphy Assessment
CN102552103B (zh) * 2010-12-20 2013-11-20 西安力邦医药科技有限责任公司 拉米夫定固体分散体、其制备方法、药物组合物和用途
WO2013183058A2 (fr) 2012-06-07 2013-12-12 Tulip Medical Ltd. Dispositif étendu
ES2926480T3 (es) 2013-12-05 2022-10-26 Epitomee Medical Ltd Dispositivos y sistemas retentivos para la liberación in situ de principios activos farmacéuticos
US20170266112A1 (en) 2014-06-11 2017-09-21 Massachusetts Institute Of Technology Residence structures and related methods
AU2015274456B2 (en) 2014-06-11 2020-03-26 Massachusetts Institute Of Technology Self-assembled residence devices and related methods
JP2018515476A (ja) 2015-05-01 2018-06-14 マサチューセッツ インスティテュート オブ テクノロジー 誘発性形状記憶誘導デバイス
CA3002916A1 (fr) 2015-10-23 2017-04-27 Lyndra, Inc. Systemes a demeure gastriques pour liberation prolongee d'agents therapeutiques et leurs procedes d'utilisation
SG11201804384UA (en) 2015-12-08 2018-06-28 Lyndra Inc Geometric configurations for gastric residence systems
AU2017336154B2 (en) 2016-09-30 2023-11-09 Lyndra Therapeutics, Inc. Gastric residence systems for sustained delivery of adamantane-class drugs
WO2019126218A1 (fr) * 2017-12-18 2019-06-27 Tris Pharma, Inc. Composition de poudre de médicament à libération modifiée comprenant des systèmes de formation de raft de rétention gastrique ayant une libération de médicament par impulsions de déclenchement
TR201914116A2 (tr) * 2019-09-17 2021-04-21 Univ Yeditepe Doğal bi̇yomateryaller i̇le kri̇yojelleri̇n üreti̇m yöntemi̇ ve bu kri̇yojelleri̇n yumuşak doku i̇skelesi̇ veya i̇laç taşiyici si̇stem olarak kullanimi
WO2022195476A1 (fr) 2021-03-15 2022-09-22 Clexio Biosciences Ltd. Dispositifs de rétention gastrique pour l'évaluation d'états intragastriques

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4764380A (en) * 1982-03-22 1988-08-16 Alza Corporation Drug delivery system comprising a volume increasing matrix containing a plurality of tiny pills
US5232704A (en) * 1990-12-19 1993-08-03 G. D. Searle & Co. Sustained release, bilayer buoyant dosage form
DE4406424A1 (de) * 1994-02-28 1995-08-31 Bayer Ag Expandierbare Arzneiformen
PT1003476E (pt) * 1997-08-11 2005-05-31 Alza Corp Forma de dosagem de agente activo de libertacao prolongada adaptada para retencao gastrica
CZ2001901A3 (cs) * 1998-09-14 2001-08-15 Ranbaxy Laboratories Limited Farmaceutická kompozice představující systém řízeného dodávání léku pro orální podání, poskytující časovou a místní kontrolu
JP2000256216A (ja) * 1999-03-04 2000-09-19 Meiji Milk Prod Co Ltd ゲル組成物
EP1305021A4 (fr) * 2000-06-23 2009-09-23 Teva Pharma Composition a expansion rapide pour retention gastrique et liberation regulee d'agents therapeutiques, et formes posologiques renfermant cette composition

Also Published As

Publication number Publication date
BR0117123A (pt) 2004-09-28
PL368327A1 (en) 2005-03-21
NZ531461A (en) 2008-03-28
JP2005501097A (ja) 2005-01-13
CN1543337A (zh) 2004-11-03
ZA200402066B (en) 2005-05-09
CA2456976A1 (fr) 2003-02-27
EP1416914A1 (fr) 2004-05-12
NO20040611L (no) 2004-04-16
MXPA04001388A (es) 2004-05-27
KR20040032918A (ko) 2004-04-17
WO2003015745A1 (fr) 2003-02-27
IL160363A0 (en) 2004-07-25

Similar Documents

Publication Publication Date Title
CO5670360A2 (es) Dispositivo de retencion gastrico expandible
DE69907977D1 (de) Pyrrolobenzodiazepine
CY1109955T1 (el) Δισκιο τροποποιημενης απελευθερωσης υδροχλωριουχου bupropion
BRPI0109198B8 (pt) emplastro tendo um apoio
SV2002000520A (es) Derivados de pirazol ref. pcs10927aajr/bb
ES2189768T3 (es) Sintesis regioselectiva de derivados de rapamicina.
HN2001000281A (es) Nuevas imidazotriazinonas sustituidas
BR0110751A (pt) Dispositivo
PT1263745E (pt) 3-fenil-5-alcoxi-1,3,4-oxadiazol-2-onas substituidas e sua utilizacao para a inibicao da lipase sensivel a hormonas
BR0314058A (pt) Composições para cuidados pessoais a base de álcool ramificado
BR9809847A (pt) Dispositivo para baixar uma âncora para o fundo do mar
ECSP034531A (es) Derivados sustituidos de c-ciclohexilmetilamina
BR0115065A (pt) Dispositivo de radiotelefonia formatável
AR030662A1 (es) Beta-tio-alfa-aminoacidos, procedimiento para su fabricacion, medicamentos que contienen estos compuestos y el uso de los tioaminoacidos para la preparacion de medicamentos
AR041113A1 (es) Composicion farmaceutica que presenta un perfil constante de liberacion de droga
AR029509A1 (es) Una composicion farmaceutica en base a un compuesto de platino (iv) y el uso de dicho compuesto para preparar medicamentos antitumorales
RS50002B (sr) Eletriptan hidrobromid monohidrat
UY26574A1 (es) " procedimiento para la separación enzimática de racematos de derivados de aminometil-aril-ciclohexanol".
BR0100828A (pt) Inibidores de corrosão
AR023668A1 (es) Nuevos derivados de benzoilguanidina con ventajosas propiedades, procedimiento para su preparacion y su utilizacion en la preparacion de medicamentos
ES1048488Y (es) Dispositivo mecanico para prolongar la ereccion del pene.
UY26523A1 (es) Derivados de aminometil-fenil-ciclohexanona, procedimiento para su preparación, el uso de los derivados de aminometil-fenil-ciclohexanona para la preparación de medicamentos que contienen los derivados de aminometil-fenil-ciclohexanona
ES1047740Y (es) Dispositivo para marcar la talla del calzado.
JPS53148865A (en) Lamp supporting device
ES1049650U (es) Dispositivo mecanico perfeccionado para prolongar la ereccion del pene

Legal Events

Date Code Title Description
FC Application refused